BusinessWire announcement detailing Profluent’s collaboration with Ensoma to develop AI-designed base editors targeting in vivo hematopoietic stem cell therapies.
Need help?
Contact usBusinessWire announcement detailing Profluent’s collaboration with Ensoma to develop AI-designed base editors targeting in vivo hematopoietic stem cell therapies.